Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer

scientific article published on 10 March 2009

Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1158/0008-5472.CAN-08-2902
P932PMC publication ID2666150
P698PubMed publication ID19276375

P50authorGeorgia Chenevix-TrenchQ17517031
Stephen ChanockQ27662321
Pamela J. ThompsonQ116977453
Hoda Anton-CulverQ28052887
Montserrat García-ClosasQ28356305
Jolanta LissowskaQ28606996
Argyrios ZiogasQ30831638
Estrid HøgdallQ30831658
Susanne Krüger KjaerQ38297251
Penelope M. WebbQ41235493
Alice S. WhittemoreQ42423380
Robert VierkantQ42681243
Australian Ovarian Cancer Study GroupQ42790423
Susan J. RamusQ45906365
Shelley S. TworogerQ46915135
Jan BlaakærQ52562626
Jonathan BeesleyQ56524232
Louise A. BrintonQ58623846
Douglas F. EastonQ59812154
David Van Den BergQ60686183
Paul D P PharoahQ61822938
Joellen M SchildkrautQ61822968
Julie M. CunninghamQ67440680
Claus K. HøgdallQ67873804
Susan E. HankinsonQ76570836
Ian JacobsQ77753455
Mark ShermanQ88087477
Ellen L GoodeQ88243694
Beata PepłońskaQ89284158
Thomas A SellersQ89445791
Anna H WuQ89864403
Daniel W. CramerQ90007566
Simon A GaytherQ91677076
Honglin SongQ91866986
Celeste Leigh PearceQ93009450
David V ContiQ93010760
Michael E CarneyQ100738685
Edwin Severin Iversen, Jr.Q102128502
Catherine M PhelanQ109543723
Kathryn L TerryQ109543794
Marc T GoodmanQ114258099
Andrew BerchuckQ114258102
Galina LurieQ114314372
Patricia G MoormanQ114314373
Valerie McGuireQ114314375
Rebecca SutphenQ114314376
Brian CalingaertQ114338156
Lydia QuayeQ114340310
P2093author name stringRebecca Anderson
Jeffrey R Marks
Xiaoqing Chen
David N Rider
Merlise A Clyde
Christopher K Elund
P2860cites workIdentification of a novel p53 functional domain that is necessary for efficient growth suppressionQ24311276
The International HapMap ProjectQ27860695
Meta-analysis in clinical trialsQ27860779
Haploview: analysis and visualization of LD and haplotype mapsQ27860955
Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancerQ28220263
Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibriumQ29615642
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasmsQ29618586
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristicsQ33330850
Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancerQ33833595
Two polymorphic variants of wild-type p53 differ biochemically and biologicallyQ33868530
Regulation and function of the p53 tumor suppressor proteinQ34245385
Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer riskQ34345107
A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumorsQ35041315
Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancerQ35828653
Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutationsQ36641252
Consortium analysis of 7 candidate SNPs for ovarian cancerQ37155532
P53 codon 72 polymorphism and correlation with ovarian and endometrial cancer in Greek women.Q38445136
An intron binding protein is required for transformation ability of p53.Q40506598
Primary structure polymorphism at amino acid residue 72 of human p53.Q40658642
TP53 intron 6 polymorphism and the risk of ovarian and breast cancer.Q42858445
Distribution of p53 codon 72 polymorphisms in ovarian tumour patients and their prognostic significance in ovarian cancer patients.Q44095287
Polymorphisms of the p53 gene in women with ovarian or endometrial carcinoma.Q44241453
Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroupQ44551246
Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations.Q45984954
Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control studyQ46151255
The influence of the p53 codon 72 polymorphism on ovarian carcinogenesis and prognosis.Q46184871
Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study.Q50545565
Evaluation of a polymorphism in intron 2 of the p53 gene in ovarian cancer patients. From the Danish "Malova" Ovarian Cancer Study.Q50574501
Common variants in mismatch repair genes and risk of invasive ovarian cancer.Q53345077
Germline polymorphism of p53 codon 72 in gynecological cancer.Q54642739
Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation.Q54685505
P53 codon 72 polymorphism and BRCA 1 and 2 mutations in ovarian epithelial malignancies in black South Africans.Q54761008
p53 polymorphism in ovarian and breast cancerQ70994813
Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumorsQ71610700
p53 polymorphism in ovarian and bladder cancerQ71852144
Prognostic Significance of p53 Mutation and p53 Overexpression in Advanced Epithelial Ovarian Cancer: A Gynecologic Oncology Group StudyQ79150763
A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancerQ80244055
Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancerQ81101652
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectovarian cancerQ172341
single-nucleotide polymorphismQ501128
P304page(s)2349-2357
P577publication date2009-03-10
P1433published inCancer ResearchQ326097
P1476titleSingle nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer
P478volume69

Reverse relations

cites work (P2860)
Q33747778A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.
Q34278861A multi-center population-based case-control study of ovarian cancer in African-American women: the African American Cancer Epidemiology Study (AACES).
Q82866392Advances in ovarian cancer disease control
Q33553322Association between DNA damage response and repair genes and risk of invasive serous ovarian cancer
Q36586393Association of common WRAP 53 variant with ovarian cancer risk in the Polish population
Q34416368BAYESIAN MODEL SEARCH AND MULTILEVEL INFERENCE FOR SNP ASSOCIATION STUDIES
Q37002955BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
Q37657957Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer
Q36246404Downregulation of the cancer susceptibility protein WRAP53β in epithelial ovarian cancer leads to defective DNA repair and poor clinical outcome
Q36487146Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk
Q33422082Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer
Q34955369Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk
Q37074094Genetics and women's health issues--the commitment of EMS to women scientists and gender-associated disease topics
Q35058278Genomics of the NF-κB signaling pathway: hypothesized role in ovarian cancer
Q36718113Global ovarian cancer health disparities
Q89582929Identifying multi-hit carcinogenic gene combinations: Scaling up a weighted set cover algorithm using compressed binary matrix representation on a GPU
Q53089359Meta-analysis shows significant association of the TP53 Arg72Pro with ovarian cancer risk.
Q49216581No association between TP53 Arg72Pro polymorphism and ovarian cancer risk: evidence from 10113 subjects.
Q34043691On the road with WRAP53β: guardian of Cajal bodies and genome integrity
Q58767113Oncogenic Activity of Wrap53 in Human Colorectal Cancer In Vitro and in Nude Mouse Xenografts
Q37446726Overexpression of WDR79 in non-small cell lung cancer is linked to tumour progression
Q35120227Overexpression of WRAP53 is associated with development and progression of esophageal squamous cell carcinoma
Q42356676Overexpression of the scaffold WD40 protein WRAP53β enhances the repair of and cell survival from DNA double-strand breaks
Q33891803Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium
Q35632374Polymorphisms in TP53 are associated with risk and survival of osteosarcoma in a Chinese population
Q33829340Relevance of DNA repair gene polymorphisms to gastric cancer risk and phenotype
Q33527422Risk of ovarian cancer and inherited variants in relapse-associated genes
Q37996440Role of common genetic variants in ovarian cancer susceptibility and outcome: progress to date from the Ovarian Cancer Association Consortium (OCAC).
Q51800031Single-strand conformational polymorphism analysis of a common single nucleotide variation in WRAP53 gene, rs2287499, and evaluating its association in relation to breast cancer risk and prognosis among Iranian-Azeri population.
Q35076240TP53 genetic polymorphisms, interactions with lifestyle factors and lung cancer risk: a case control study in a Chinese population
Q33967373Telomerase Cajal body protein 1 depletion inhibits telomerase trafficking to telomeres and induces G1 cell cycle arrest in A549 cells
Q35804614The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer
Q34775177The inherited genetics of ovarian and endometrial cancer
Q38806266The proximity ligation assay reveals that at DNA double-strand breaks WRAP53β associates with γH2AX and controls interactions between RNF8 and MDC1.
Q34697751The scaffold protein WRAP53β orchestrates the ubiquitin response critical for DNA double-strand break repair
Q34099786Variation at 8q24 and 9p24 and risk of epithelial ovarian cancer
Q34340254WRAP53 is an independent prognostic factor in rectal cancer- a study of Swedish clinical trial of preoperative radiotherapy in rectal cancer patients
Q30499635WRAP53 promotes cancer cell survival and is a potential target for cancer therapy
Q39017292Women who deliver twins are more likely to smoke and have high frequencies of specific SNPs: Results from a sample of African-American women who delivered preterm, low birth weight babies.
Q34177267Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk

Search more.